<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title></title></head><body><div><p style="background-color:#ffffff; margin:0pt 0pt 7.5pt; text-align:center"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Written evidence </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">from The College of Optometrists</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> (LTC 19)</span></p><p style="background-color:#ffffff; margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Summary</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:11.54pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The main causes of sight loss in the UK are long term conditions: </span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">age-related macular degeneration</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> diabetic retinopathy and glaucoma.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> Reducing preventable sight loss from these conditions is an objective in the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">Public health outcomes framework</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:11.54pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">O</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ur</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> ag</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing population and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the introduction of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">new treatments mean that demand for services to treat these eye conditions is increasing.</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:11.54pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">S</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ervices’ ability to diagnose and treat people</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> quickly and effectively varies across the country meaning</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> that people </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in some areas </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">are </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">probably </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">losing their sight</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to preventable causes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:11.54pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Local Eye Health Networks </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">alongside</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> b</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">etter use of community eye care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and data sharing have key roles to play in</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> minimis</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">preventable sight loss from long term eye conditions</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ul></ul><p style="background-color:#ffffff; margin:0pt 0pt 0pt 72pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:bold; margin:0pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Long term eye conditions: </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">rising numbers and the impact of sight loss</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Three long term conditions are responsible for most cases of sight loss in the UK: age-related macular degeneration (AMD), diabetic retinopathy and glaucoma. </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">AMD</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">is the biggest cause of sight loss in the UK.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A recent study estimated that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">2.4% of people in the UK </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">aged 50</span><span style="font-family:Arial; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">years or more had advanced wet AMD, increasing to 4.8% of those aged 65</span><span style="font-family:Arial; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">years or more and 12.2% of those aged 80</span><span style="font-family:Arial; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">years or more</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Smokers are three times more likely to suffer AMD</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 7.5pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The following table shows how the number of people with advanced AMD is predicted to rise</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">by a third</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to 679,000 this decade</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (the middle line shows prevalence amongst women and the bottom line prevalence amongst men):</span></p><p style="margin:0pt 0pt 10pt"><div style='width:376pt; height:248pt;'><img src="data:image/jpeg;base64,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" width="468" height="329" alt="An external file that holds a picture, illustration, etc.&#xA;Object name is bjophthalmol-2011-301109fig2.jpg" style="margin-left:25.05pt; margin-top:1.15pt; position:absolute; z-index:-65535" /></div><br style="page-break-before:always; clear:both" /></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.4.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Diabetic retinopathy</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> is the biggest cause of sight loss amongst pe</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ople of working age in the UK.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">It occurs when diabetes weakens the blood vessels in the eye.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">People with diabetes are 25 times more likely than the general population to become blind</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Diabetes UK estimates that by 2025 there will be 5 million people in</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> England </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">with diabetes</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and for each year someone lives with diabetes, their risk of retinopathy increases.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.5.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Glaucoma</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> is estimated to affect about half a million people in England.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The prevalence of glaucoma rises steeply with advancing age.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">African-Caribbean people are at particular risk.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">More than half of those glaucoma cases are thought to be undetected</span><a name="_ftnref6"></a><a href="#_ftn6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.6.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The Government is committed to reducing preventable sight loss from these three long term conditions through an indicator in its </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">Public health outcomes framework</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We strongly support this.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.7.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Sight loss has a major impact on people’s well being.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Sight is the sense people most fear losing.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Over one-third of older people with sight loss are also living with depression</span><a name="_ftnref7"></a><a href="#_ftn7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. Two-thirds of registered blind and partially sighted people of working age are not in paid employment</span><a name="_ftnref8"></a><a href="#_ftn8">[8]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">1.8.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">People with a long term eye condition often have other health problems</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> too</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Sight loss is associated with a heightened risk of falls and fractures</span><a name="_ftnref9"></a><a href="#_ftn9">[9]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and people with a long term eye condition</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> often have </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">other </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">long term condition</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, such as dementia</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and diabetes.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:bold; margin:0pt 0pt 0pt 13.25pt; padding-left:4.75pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">The </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">capacity</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">of existing services to meet future demand</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">2.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There is emerging evidence that eye care services are unable to meet current demand and will not meet rising demand in the future without significant improvements.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">2.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A recent survey found that half of all hospital eye units in England were unable to treat AMD patients within the recommended waiting times that would mini</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">mise their risk of sight loss</span><a name="_ftnref10"></a><a href="#_ftn10">[10]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">2.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Professor Sir Bruce Keogh</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">’s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">evidence</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to the Health Select Committee in January t</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">hat cataract </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">surgery</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> was being rationed inappropriately by </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">half of PCTs</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">highlighted</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the strain hospital eye units are under as they str</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">uggle to meet existing demand, much of which is fuelled by long term conditions.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">2.4.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Our recent report, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">Better data, better care </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">showed how the NHS’ reliance on paper forms for payment and referrals hindered care and wasted valuable time and resources in the fight to prevent sight loss from long term eye conditions</span><a name="_ftnref11"></a><a href="#_ftn11">[11]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The failure to enable community and secondary care teams to share data is a major drag on the capacity of existing eye care services to meet demand now and in the future.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:bold; margin:0pt 0pt 0pt 13.55pt; padding-left:4.6pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Taking advantage of community optometrists to redesign services, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">meet demand</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> integrate care a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">round patients’ needs</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.4pt; text-indent:-21.55pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are examples of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">innovation, which</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> if properly implement</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ed</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> across the NHS, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">would</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> boost our capacity to meet the needs of people with long term eye conditions in the future.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Taking glaucoma care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> for example, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NICE recommends that patients at risk of glaucoma be monitored in t</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">he community by optometrists th</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rough ‘repeat measures’ schemes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> rather</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> than</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in hospitals</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">More advanced monitoring</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in the community</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (referral refinement)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> is also recommended by the College of Optometrists and the Royal College of Ophthalmologists</span><a name="_ftnref12"></a><a href="#_ftn12">[12]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Together, these schemes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> im</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">prove </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">glaucoma </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">patients’ access to quality care by increas</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the capacity of eye services.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">They </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">keep less serious cases out of hospitals and take advantage of thousands of community optometrists already performing sight test</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">caring for patients </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the NHS.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">They can also save significant amounts of money; NHS Evidence found that moving repeat measurement for glaucoma in </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the community </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in Bexley </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">was 62% cheaper than the equivalent hospital tariff</span><a name="_ftnref13"></a><a href="#_ftn13">[13]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">To minimise sight loss from AMD, Gloucestershire has introduced a one stop shop model with integrated IT. Rather than assessing and treating patients over two visits, here assessment and treatment clinics run in parallel using non-consultant staff in particular nurse practitioners and optometrists. All clinical data is recorded electronically, allowing the consultant to make rapid treatment decisions for new and returning wet AMD patients using information on patient electronic medical records</span><a name="_ftnref14"></a><a href="#_ftn14">[14]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.4.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In most of England, we do not know the answer to simple questions like, how many patients are we</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> treating for glaucoma or if at risk groups </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">get their eyes examined.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Scotland has been particularly innovative </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> overcoming IT barriers </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">by</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> integrat</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing the electronic systems of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> community optometrists and hospitals eye unit </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">improve access to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">better </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">quality care and improve efficiency at the same time.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Following a successful pilot, the Scottish Government is committed to ensuring that 95% of referrals from community optometrists to hospitals are done elect</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ronically rather than in paper.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Paper referrals are the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">norm in most of England.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Moving to e</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">lectronic referral means community and hospital clinicians can share much more information about their patients over time with the aim </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> improv</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the continuity of care, reduc</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> unnecessary referrals to the hospitals, improv</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> efficiency and improv</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> patient outcomes.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.5.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Scotland is also working towards </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">making </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">provider payment forms electronic</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Electronic payment facilitates much better data collection about who is accessing eye care and how to design services that improve the care of populations with long term eye conditions.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, in England, most optometrists </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">must submit their payment forms, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">which include potentially valuable public health data, in paper form making it extremely difficult to analyse</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the data </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> improve eye health services</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.6.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">If accomplished, the Governments push for a paperless NHS offers great potential to improve eye care for people with long term conditions.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 7.5pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:normal; font-weight:normal">3.7.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The move to involve clinicians more closely in commissioning also offers potential to improve care.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NHS England is introducing Local Eye Health Networks in to each local team area</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to bring together commissioners, community and hospital clinicians and patient groups to work together to assess local need and improve the quality and efficiency of eye health services for their local population.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We strongly recommend that commissioners take advantage of these networks and are supporting our members so they can contribute fully.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 7.5pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">May 2013</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Department of Health (2012), Public Health Outcomes Framework</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Healthy</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> liv</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">e</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">s, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">healthy people: Improving outcomes and supporting transparency</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Available from https://www.gov.uk/government/publications/public-health-outcomes-framework-update</span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> O</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">wen</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">, C.G et al (2012) The estimated prevalence and incidence of late stage age related macular degeneration in the UK. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Br J </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Ophthalmol</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">2012;96:5</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">752-756</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Cong, R. et al (2008). Smoking and the risk of age-related macular degeneration: a meta-analysis. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Ann </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Epidemiol</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">; 18:647–656.</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">macrovascular</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">microvascular</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> complications in type 2 diabetes: UKPDS 38. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">BMJ</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">1998;317:703</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Diabetes UK (2012) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">State of the nation 2012: England</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Available from </span><a href="http://www.diabetes.org.uk/Documents/Reports/State-of-the-Nation-2012.pdf"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://www.diabetes.org.uk/Documents/Reports/State-of-the-Nation-2012.pdf</span></a></p><p style="margin:0pt"><a name="_ftn6"></a><a href="#_ftnref6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Burr JM, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Mowatt</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> G, Hernandez R et al (2007) The clinical and cost effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Health </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Technol</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic"> Assess</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">; 11(41): iii-iv, ix-x, 1-190. </span></p><p style="margin:0pt"><a name="_ftn7"></a><a href="#_ftnref7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Barr, W et al (2010</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">) </span><a href="http://www.research.lancs.ac.uk/portal/en/publications/evaluation-of-emotional-support-and-counselling-within-an-integrated-low-vision-service(4fa42824-a0cc-41cf-bcdb-a86b6868b262).html"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Evaluation of Emotional Support and Counselling within an Integrated Low Vision Service.</span></a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Liverpool : Health and Community Care Research Unit, University of Liverpool, 2010. </span></p><p style="margin:0pt"><a name="_ftn8"></a><a href="#_ftnref8">[8]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:6pt; vertical-align:super"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Douglas, G., Corcoran, C. and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Pavey</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">, S. (2006</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">), Network 1000. Opinions and circumstances of visually impaired people in Great Britain: Report based on over 1000 interviews</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">. Birmingham: Visual Impairment Centre for Teaching and Research, School of Education, University of Birmingham.</span></p><p style="margin:0pt"><a name="_ftn9"></a><a href="#_ftnref9">[9]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">College of Optometrists &amp; British Geriatrics Society (2011) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">The Importance of Vision in Preventing Falls</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">. Available from </span><a href="http://www.college-optometrists.org/en/utilities/document-summary.cfm/docid/99A3825F-3E6C-44DA-994D4B42DC1AF5A4"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://www.college-optometrists.org/en/utilities/document-summary.cfm/docid/99A3825F-3E6C-44DA-994D4B42DC1AF5A4</span></a></p><p style="margin:0pt"><a name="_ftn10"></a><a href="#_ftnref10">[10]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:6pt; vertical-align:super"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Macular Society (2012)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Half of eye clinics fail to meet guidance on waiting times</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Available from </span><a href="http://www.macularsociety.org/How-we-help/About-us/Newsroom/News-stories/Half-of-eye-clinics-fail-to-meet-guidance-on-waiting-times"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://www.macularsociety.org/How-we-help/About-us/Newsroom/News-stories/Half-of-eye-clinics-fail-to-meet-guidance-on-waiting-times</span></a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span></p><p style="margin:0pt"><a name="_ftn11"></a><a href="#_ftnref11">[11]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> The College of Optometrist (2013) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Better data, better care: ophthalmic public health data report</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">. Available from </span></p><p style="margin:0pt"><a href="http://www.college-optometrists.org/en/utilities/document-summary.cfm?docid=BEA30498-BFEC-4CEF-8F2DBD6985E0617E"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://www.college-optometrists.org/en/utilities/document-summary.cfm?docid=BEA30498-BFEC-4CEF-8F2DBD6985E0617E</span></a></p><p style="margin:0pt"><a name="_ftn12"></a><a href="#_ftnref12">[12]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">The College of Optometrists and The Royal College of Ophthalmologists (2013) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Commissioning better eye care: glaucoma</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Available from </span><a href="http://www.college-optometrists.org/filemanager/root/site_assets/policies_and_postition_papers/joint_college_glaucoma_final_20_3_13.pdf"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://www.college-optometrists.org/filemanager/root/site_assets/policies_and_postition_papers/joint_college_glaucoma_final_20_3_13.pdf</span></a></p><p style="margin:0pt"><a name="_ftn13"></a><a href="#_ftnref13">[13]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">NHS Evidence (2011) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">NICE QIPP case study: Avoiding Unnecessary Referral For Glaucoma: Use Of A Repeat Measurement scheme</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">. Available from: https://www.evidence.nhs.uk/</span></p><p style="margin:0pt"><a name="_ftn14"></a><a href="#_ftnref14">[14]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Amoaku</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">, W</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> et al.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> (2012)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Action on AMD.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Optimising patient management: act now to ensure current and continual delivery of best possible patient care. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt; font-style:italic">Eye</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> 26, S2–S21; doi:10.1038/eye.2011.343</span></p></body></html>